Application Information

This drug has been submitted to the FDA under the reference 202402/001.

Names and composition

"IBUPROFEN LYSINE" is the commercial name of a drug composed of IBUPROFEN LYSINE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
202402/001 IBUPROFEN LYSINE IBUPROFEN LYSINE INJECTABLE/INTRAVENOUS EQ 20MG BASE per 2ML (EQ 10MG BASE per ML)

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
021903/001 NEOPROFEN IBUPROFEN LYSINE INJECTABLE/INTRAVENOUS EQ 20MG BASE per 2ML (EQ 10MG BASE per ML)
202402/001 IBUPROFEN LYSINE IBUPROFEN LYSINE INJECTABLE/INTRAVENOUS EQ 20MG BASE per 2ML (EQ 10MG BASE per ML)

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved